secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001104659-24-001504
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liquidia raises $100M: $75M equity private placement + $25M debt from HCR
-------------------------------------------------------------------------

- Private placement of 7,182,532 shares at $10.442/share (8% discount to Jan 3 close) to Patient Square Capital affiliate; gross proceeds ~$75M.
- Fourth amendment to RIFA funds additional $25M from HCR, bringing total drawn to $67.5M; remaining $32.5M available upon mutual agreement.
- CFO says combined $126M (including Dec 2023 offerings) positions company to reach profitability if YUTREPIA launches by April 2024.
- Proceeds to fund commercial development, clinical trials for YUTREPIA (PAH/PH-ILD) and L606, plus general corporate purposes.
- Equity issuance expected to close January 8, 2024; no broker fees paid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924001504/0001104659-24-001504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924001504/tm242158d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-001504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer